MedPath

Sulindac

Sulindac Tablets USP, 150 mg and 200 mgRx only

Approved
Approval ID

ddbbaada-f55a-4032-a24c-a8c493933a45

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 25, 2021

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Sulindac

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-4976
Application NumberANDA072711
Product Classification
M
Marketing Category
C73584
G
Generic Name
Sulindac
Product Specifications
Route of AdministrationORAL
Effective DateApril 22, 2019
FDA Product Classification

INGREDIENTS (5)

SULINDACActive
Quantity: 200 mg in 1 1
Code: 184SNS8VUH
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE K29/32Inactive
Code: 390RMW2PEQ
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sulindac - FDA Drug Approval Details